Evaluating Bloodletting and DSCB Treatment for Avabahuka w.s.r. to Periarthritis Shoulder

A Clinical Study to Evaluate the Efficacy of Siravedhan and Distal Sodium Channel Block (DSCB) in the management of Avabahuka w.s.r. to Periarthritis Shoulder. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103488

Enrollment

Registered

2026-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a) Clinically diagnosed patients of Avabahuka (Periarthritis Shoulder). b) Patients willing for trial and give informed and written consent. c) Patients of either gender from 40 yrs to 60 years.

Exclusion criteria

Exclusion criteria: a) Patients not willing for trial or not ready to give consent. b) Patients with localized infection at the site of Siravedhan and DSCB infiltration. c) Patients having history of trauma at same site. d) Patients suffering from Bleeding Disorders. e) ICTC and HBsAg positive patients. f) Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
A Clinical Study to Evaluate the Efficacy of Siravedhan and Distal Sodium Channel Block (DSCB) in Avabahuka w.s.r.Periarthritis Shoulder. Timepoint: 45 days	—

Secondary

Measure	Time frame
To evaluate improvement in pain, ROM & overall fundamental outcomes. To evaluate the untoward effect, complications & safety measures.Timepoint: 45days	—

Countries

India

Contacts

Public ContactProf. Anil Kumar Sharma

R.G.G.P.G.Ayurvedic college and hospital Paprola. Address

dranilpaprola@gmail.com9805056393

Outcome results